Health UPdates #200 “BABAE, MAHALAGA KA…” Cervical Cancer Prevention, Screening, and Treatment

The University of the Philippines,
in partnership with the UP Manila – National Institutes of Health,
and in cooperation with UP Philippine General Hospital and UP College of Medicine,
would like to invite you to attend this webinar!

Registration slots are limited to this HEALTH UPDATES webinar
So sign up NOW:
bit.ly/HealthUpdatesWebinar200

Webinar #200
July 12, 2024 (Friday) 12nn
“BABAE, MAHALAGA KA…”
Cervical Cancer Prevention, Screening, and Treatment

Presenter:
DR. CAROLYN R. ZALAMEDA-CASTRO
President, Philippine Society for Cervical Pathology and Colposcopy
Chair, Task Force on Women First (Reproductive Health Committee), Philippine Obstetrical and Gynecological Society
Board Secretary, Society of Gynecologic Oncologists of the Philippines, Inc.
Clinical Associate Professor, Department of Obstetrics and Gynecology, UP – Philippine General Hospital and Medical Center Manila

———————————————————–

Webinar #200
July 12, 2024 (Friday) 12nn
“BABAE, MAHALAGA KA…”
Cervical Cancer Prevention, Screening, and Treatment

Cervical cancer remains a significant public health concern in the Philippines, with high mortality rates despite being largely preventable. In this week’s episode, we will discuss the recent advancements in cervical cancer prevention including the Human Papillomavirus (HPV) vaccine, a highly effective tool in curbing the incidence of this HPV-driven malignancy. We will discuss the latest data on vaccine efficacy, addressing questions on its ability to prevent high-risk HPV strains (HPV 16 and 18) responsible for the majority of cervical cancers.

We will explore the current availability and accessibility of the HPV vaccine in the Philippines while also addressing concerns regarding cost-effectiveness and potential barriers to widespread vaccination. Moreover, we will aim to offer valuable insights on promoting vaccine awareness and overcoming vaccine hesitancy within the population.

Moving beyond prevention, we will also explore updates in cervical cancer screening including the latest recommendations for Pap smear screening intervals, alongside the potential role of HPV DNA testing as a primary screening method in the Philippines. This will be a crucial discussion, considering the World Health Organization’s recent shift towards HPV-based testing for its superior detection of precancerous lesions. Finally, we will showcase advancements in cervical cancer treatment, including minimally invasive surgical techniques and targeted therapies.

We have an excellent speaker this week, Dr. Carolyn R. Zalameda-Castro, who is the current President of the Philippine Society for Cervical Pathology and Colposcopy and also the Chair of the Task Force on Women First of the Philippine Obstetrical and Gynecological Society.

By the end of this webinar, we hope the audience members have been updated on the critical aspects of cervical cancer prevention, screening, and treatment. Together, we can make a significant impact in reducing the burden of cervical cancer in the Philippines.

Together, we can stop preventable deaths.